Claudia Jessen-Trefzer Lab - old bugs novel drugs

Drug anchoring in the cell membrane

Drug impermeability and efflux are two major hurdles in the drug development process of anti-microbial agents, which often lead to failure of many target based screenings at an advanced state of research. Anchoring small molecule drugs covalently to mycobacterial components, especially the mycobacterial membrane is potentially a solution that tackles the above mentioned challenges.

Two important glycolipids: trehalose dimycolate and trehalose monomycolate

The outer leaflet of the mycobacterial cell envelop consists of small and extractable lipids and contains the essential non-mammalian disaccharide sugar trehalose alongside with the glycolipids trehalose dimycolate (TDM) and trehalose monomycolate (TMM). We synthesize trehalose-photosensitizer conjugates that are covalently incorporated into the mycomembrane via an enzyme mediated transformation in the periplasm. The toxophores are then activated by light and kill mycobacteria via release of singlet oxygen species with very high efficiencies.

For more information, please see Trehalose Conjugation Enhances Toxicity of Photosensitizers against Mycobacteria

Schlenk flask (cylindrical)
Schlenk flask (cylindrical)